For the first time, a Vanderbilt Health patient has been implanted with a novel left atrial pressure monitoring device (the V-LAP device), part of a clinical trial being conducted at only five centers in the United States.

Adetola Kassim, MBBS (Hematology and Oncology), is co-first author of the paper that reported of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.

The MNPS Certificated Employee Health Plan covers 6,500 active teachers plus 11,500 retirees and dependents.

Andreana Holowatyj, PhD, MSCI (Epidemiology), is chair of the Scientific Advisory Board for the ACPMP Research Foundation, and the article’s lead author.

An interim plan has been announced to fill the roles held by Alvin C. Powers, MD, in Vanderbilt’s Division of Diabetes, Endocrinology and Metabolism.